These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 24156409

  • 21. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G, Armbruster N, Bodenhöfer M, Haerle U, Behrens D, Buchholz M, Rothbauer U, Sipos B, Schmees C.
    Oncotarget; 2016 Nov 08; 7(45):73725-73738. PubMed ID: 27713160
    [Abstract] [Full Text] [Related]

  • 22. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition.
    Ren D, Minami Y, Nishita M.
    Genes Cells; 2011 Mar 08; 16(3):304-15. PubMed ID: 21342370
    [Abstract] [Full Text] [Related]

  • 23. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
    Douchi D, Ohtsuka H, Ariake K, Masuda K, Kawasaki S, Kawaguchi K, Fukase K, Oikawa M, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M.
    Cancer Lett; 2015 Aug 28; 365(1):132-40. PubMed ID: 26047573
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ, Chen S, Gu JN, Zhu Y, Zhan Q, Cheng DF, Chen H, Deng XX, Shen BY, Peng CH.
    J Cell Biochem; 2018 Jan 28; 119(1):1027-1040. PubMed ID: 28685847
    [Abstract] [Full Text] [Related]

  • 25. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
    Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, Weeraratna AT.
    J Biol Chem; 2007 Jun 08; 282(23):17259-71. PubMed ID: 17426020
    [Abstract] [Full Text] [Related]

  • 26. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
    Lee SE, Lim SD, Kang SY, Suh SB, Suh YL.
    Brain Pathol; 2013 Jul 08; 23(4):445-53. PubMed ID: 23278988
    [Abstract] [Full Text] [Related]

  • 27. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.
    Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, Wu J, Li M.
    J Clin Invest; 2013 Feb 08; 123(2):566-79. PubMed ID: 23321667
    [Abstract] [Full Text] [Related]

  • 28. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER, Das AM, Helvensteijn W, Franken PF, Swagemakers S, van der Valk MA, ten Hagen TL, Kuipers EJ, van Veelen W, Smits R.
    Carcinogenesis; 2013 Nov 08; 34(11):2629-38. PubMed ID: 23764752
    [Abstract] [Full Text] [Related]

  • 29. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, Minami Y.
    Oncogene; 2009 Sep 10; 28(36):3197-208. PubMed ID: 19561643
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma.
    Lu W, Wei W, de Bock GH, Zhou H, Li Q, Shen X.
    Int J Clin Oncol; 2014 Dec 10; 19(6):1011-9. PubMed ID: 24395444
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
    Trifa F, Karray-Chouayekh S, Jmal E, Jmaa ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J, Mokdad-Gargouri R.
    Tumour Biol; 2013 Jun 10; 34(3):1625-33. PubMed ID: 23417837
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD, Hu B, Cen G, Yang YH, Chen WW, Guo ZY, Wang XF, Zhao Q, Qiu ZJ.
    World J Gastroenterol; 2020 May 21; 26(19):2349-2373. PubMed ID: 32476798
    [Abstract] [Full Text] [Related]

  • 37. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Masugi Y, Yamazaki K, Emoto K, Effendi K, Tsujikawa H, Kitago M, Itano O, Kitagawa Y, Sakamoto M.
    Lab Invest; 2015 Mar 21; 95(3):308-19. PubMed ID: 25599535
    [Abstract] [Full Text] [Related]

  • 38. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP, Chaurasiya SK, Guilmain W, Andersson T.
    J Exp Clin Cancer Res; 2016 Sep 13; 35(1):144. PubMed ID: 27623766
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, Srivastava G, Tao Q.
    Cancer Biol Ther; 2010 Sep 15; 10(6):617-24. PubMed ID: 20603606
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.